FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037132298> ?p ?o ?g. }

• W3037132298 abstract "Abstract Background Pepsin agglutinators, discovered over 50 years ago, have been recently referred to as anti-hinge antibodies (AHAs) because of their reaction with the IgG hinge epitope. AHAs have different reactivity for each hinge epitope generated by each protease that cleaves the hinge region at different sites. Moreover, AHAs have different reactivity against different hinge epitopes derived from each IgG subclass even when the same protease is used. Since the expression of matrix metalloproteinase-3 (MMP-3) is enhanced in rheumatoid arthritis (RA), AHA production could also be increased. The purpose of this study was to determine whether the levels of AHAs against IgG hinge epitopes produced by MMP-3 are elevated in RA. Methods The serum levels of IgG or IgA AHAs against the IgG1/IgG4 F(ab’) 2 fragments, generated by either MMP-3 or pepsin, were measured using ELISA in 111 patients with RA and 81 healthy controls (HC). Receiver operating characteristic (ROC) analysis was used for obtaining optimal cutoff values and cutoff values indicating high specificity (> 95%) of the AHA. The targeted epitope of a specific AHA was investigated through inhibition ELISA. Results Seven AHAs were statistically higher in RA patients than in HC, except IgG AHA against IgG1 F(ab’) 2 , which was generated by MMP-3 proteolytic cleavage. The areas under the ROC curve were 0.66–0.80, although the sensitivities at high specificity were low (5.4–24.3%). The cumulative number of positive AHAs in each individual was statistically higher in RA patients than in HC, suggesting the extreme extent of AHA repertoires in RA. Inhibition studies revealed that IgG AHAs against IgG4 F(ab’) 2 fragments generated by pepsin cross-reacted with IgG1 F(ab’) 2 fragments generated by pepsin. Multivariate logistic regression analysis identified the IgG AHA against IgG4 F(ab’) 2 fragments generated by pepsin as an independent variable for RA diagnosis, even in RA patients who were negative for both RF and ACPA (odds ratio 1.18, 95% CI 1.06–1.32; P = 0.003). Additional experiments using non-RA patients finally strengthened the diagnostic utility. Conclusion In RA patients, we observed diversification and amplification of AHA repertoires and diagnostic utility of the specific AHA against IgG4 F(ab’) 2 fragments generated by pepsin but not MMP-3." @default.
• W3037132298 created "2020-07-02" @default.
• W3037132298 creator A5044665470 @default.
• W3037132298 creator A5050792264 @default.
• W3037132298 creator A5082810599 @default.
• W3037132298 creator A5088776626 @default.
• W3037132298 date "2020-06-26" @default.
• W3037132298 modified "2023-10-05" @default.
• W3037132298 title "IgG anti-hinge antibodies against IgG4 F(ab’)2 fragments generated using pepsin are useful diagnostic markers for rheumatoid arthritis: implications of the possible roles of metalloproteinases and IgG subclasses in generating immunogenic hinge epitopes" @default.
• W3037132298 cites W1667684715 @default.
• W3037132298 cites W1913865297 @default.
• W3037132298 cites W1968981498 @default.
• W3037132298 cites W1974015269 @default.
• W3037132298 cites W1980024538 @default.
• W3037132298 cites W1994356254 @default.
• W3037132298 cites W2004762925 @default.
• W3037132298 cites W2004884683 @default.
• W3037132298 cites W2011728654 @default.
• W3037132298 cites W2012130146 @default.
• W3037132298 cites W2014190363 @default.
• W3037132298 cites W2019590981 @default.
• W3037132298 cites W2028431762 @default.
• W3037132298 cites W2045730380 @default.
• W3037132298 cites W2047290341 @default.
• W3037132298 cites W2081820657 @default.
• W3037132298 cites W2085192554 @default.
• W3037132298 cites W2089686042 @default.
• W3037132298 cites W2103819978 @default.
• W3037132298 cites W2115091491 @default.
• W3037132298 cites W2117109249 @default.
• W3037132298 cites W2146321760 @default.
• W3037132298 cites W2149768460 @default.
• W3037132298 cites W2152348310 @default.
• W3037132298 cites W2161222221 @default.
• W3037132298 cites W2337245168 @default.
• W3037132298 cites W2557204062 @default.
• W3037132298 cites W2592135754 @default.
• W3037132298 cites W2620068414 @default.
• W3037132298 cites W2886363262 @default.
• W3037132298 cites W4211111012 @default.
• W3037132298 cites W4239110824 @default.
• W3037132298 cites W4242906786 @default.
• W3037132298 doi "https://doi.org/10.1186/s13075-020-02251-7" @default.
• W3037132298 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7318515" @default.
• W3037132298 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32586370" @default.
• W3037132298 hasPublicationYear "2020" @default.
• W3037132298 type Work @default.
• W3037132298 sameAs 3037132298 @default.
• W3037132298 citedByCount "1" @default.
• W3037132298 countsByYear W30371322982023 @default.
• W3037132298 crossrefType "journal-article" @default.
• W3037132298 hasAuthorship W3037132298A5044665470 @default.
• W3037132298 hasAuthorship W3037132298A5050792264 @default.
• W3037132298 hasAuthorship W3037132298A5082810599 @default.
• W3037132298 hasAuthorship W3037132298A5088776626 @default.
• W3037132298 hasBestOaLocation W30371322981 @default.
• W3037132298 hasConcept C126322002 @default.
• W3037132298 hasConcept C153911025 @default.
• W3037132298 hasConcept C159654299 @default.
• W3037132298 hasConcept C16311235 @default.
• W3037132298 hasConcept C181199279 @default.
• W3037132298 hasConcept C185592680 @default.
• W3037132298 hasConcept C195616568 @default.
• W3037132298 hasConcept C203014093 @default.
• W3037132298 hasConcept C2776714187 @default.
• W3037132298 hasConcept C2777575956 @default.
• W3037132298 hasConcept C2780632150 @default.
• W3037132298 hasConcept C2780898057 @default.
• W3037132298 hasConcept C55493867 @default.
• W3037132298 hasConcept C71924100 @default.
• W3037132298 hasConcept C86803240 @default.
• W3037132298 hasConceptScore W3037132298C126322002 @default.
• W3037132298 hasConceptScore W3037132298C153911025 @default.
• W3037132298 hasConceptScore W3037132298C159654299 @default.
• W3037132298 hasConceptScore W3037132298C16311235 @default.
• W3037132298 hasConceptScore W3037132298C181199279 @default.
• W3037132298 hasConceptScore W3037132298C185592680 @default.
• W3037132298 hasConceptScore W3037132298C195616568 @default.
• W3037132298 hasConceptScore W3037132298C203014093 @default.
• W3037132298 hasConceptScore W3037132298C2776714187 @default.
• W3037132298 hasConceptScore W3037132298C2777575956 @default.
• W3037132298 hasConceptScore W3037132298C2780632150 @default.
• W3037132298 hasConceptScore W3037132298C2780898057 @default.
• W3037132298 hasConceptScore W3037132298C55493867 @default.
• W3037132298 hasConceptScore W3037132298C71924100 @default.
• W3037132298 hasConceptScore W3037132298C86803240 @default.
• W3037132298 hasIssue "1" @default.
• W3037132298 hasLocation W30371322981 @default.
• W3037132298 hasLocation W30371322982 @default.
• W3037132298 hasLocation W30371322983 @default.
• W3037132298 hasLocation W30371322984 @default.
• W3037132298 hasLocation W30371322985 @default.
• W3037132298 hasLocation W30371322986 @default.
• W3037132298 hasLocation W30371322987 @default.
• W3037132298 hasOpenAccess W3037132298 @default.
• W3037132298 hasPrimaryLocation W30371322981 @default.
• W3037132298 hasRelatedWork W2007362700 @default.
• W3037132298 hasRelatedWork W2051020213 @default.
• W3037132298 hasRelatedWork W2068999859 @default.
• W3037132298 hasRelatedWork W2079821383 @default.

• next